Blockade of neuronal facilitatory nicotinic receptors containing α3β2 subunits contribute to tetanic fade in the rat isolated diaphragm

Synapse

Volumn 49, Issue 2, 2003, Pages 77-88

  Faria, Miguel ^a   Oliveira, Laura ^a   Timóteo, M Alexandrina ^a   Lobo, M Graça ^a   Correia De Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Acetylcholine release; Muscle relaxants; Neuromuscular junction; Safety factor

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ALPHA CONOTOXIN MII; CONOTOXIN; DIHYDRO BETA ERYTHROIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DEPRESSION; CONTROLLED STUDY; DIAPHRAGM MUSCLE; EXCITATORY JUNCTION POTENTIAL; FACILITATION; FEMALE; FREQUENCY MODULATION; HEMIDIAPHRAGM; MALE; MUSCLE TETANIC CONTRACTION; MUSCLE TONE; NERVE POTENTIAL; NONHUMAN; PHRENIC NERVE; POTENCY DISORDER; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TETANIC FADE;

ACETYLCHOLINE; ANIMALS; DIAPHRAGM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MUSCLE CONTRACTION; NEURONS; NICOTINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC;

EID: 0038131082     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10211     Document Type: Article

References (60)

1. Adem A, Karlsson E. 1997. Muscarinic receptor subtype selective toxins. Life Sci 60:1069-1076.
2. 3H]acetylcholine release from the rat isolated left hemidiaphragm. Naunyn Schmied Arch Pharmacol 352:646-652.
3. Bowman WC. 1980. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 59:935-943.
4. Bowman WC, Marshall IG, Gibb AJ, Harborne AJ. 1988. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci 9:16-20.
5. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM. 1996. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271:7522-7528.
6. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. 1997. Pharmacological characterization of recombinant human neuronal acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
7. Chen D, Patrick JW. 1997. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit. J Biol Chem 272:24024-24029.
8. Colquhoun D, Mathie A, Mulrine NK, Ogden DC. 1989. Studies on single acetylcholine-receptor channels in muscle endplate and sympathetic neurons. In: Sellin LC, Libelius R, Thesleff S, editors. Neuromuscular junction. Amsterdam: Elsevier Science. p 217-234.
9. Conroy WG, Berg DK. 1995. Neurons maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270:4424-4431.
10. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol 271:349-355.
11. Correia-de-Sá P, Sebastião AM, Ribeiro JA. 1991. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat. Br J Pharmacol 103:1614-1620.
12. 3H]acetylcholine release from the rat motor-nerve endings. Eur J Pharmacol 406:355-362.
13. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, Moczydlowski E. 1985. Conus geographus toxins that discriminates between neuronal and muscle sodium channels. J Biol Chem 260: 9280-9288.
14. De Oliveira MJ, Oliveira AC. 1999. Mechanisms underlying the vecuronium-induced tetanic fade in the isolated rat muscle. Pharmacol Toxicol 85:282-287.
15. Del Castillo J, Katz B. 1954. Quantal components of the endplate potential. J Physiol (Lond) 124:560-573.
16. Domet MA, Webb CE, Wilson DF. 1995. Impact of α-bungarotoxin on transmitter release at the neuromuscular junction of the rat. Neurosci Lett 199:49-52.
17. Dwoskin LP, Crooks PA. 2001. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther 298:395-402.
18. + channels. Toxicon 39:1871-1882.
19. Flores CM, DeCamp RM, Kilo S, Rogers SW, Hargreaves KM. 1996. Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of alpha3beta4, a novel subtype in the mammalian nervous system. J Neurosci 16:7892-7901.
20. Foldes FF, Chaudhry IA, Kinjo M, Nagashima H. 1989. Inhibition of mobilization of acetylcholine: the weak link in neuromuscular transmission during partial neuromuscular block with d-tubocurarine. Anesthesiology 71:218-223.
21. Gibb AJ, Marshall IG. 1984. Pre- and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat. J Physiol (Lond) 361:275-297.
22. Gibb AJ, Marshall IG. 1986. Nicotinic antagonists produce different amounts of tetanic fade in the isolated diaphragm of the rat. Br J Pharmacol 89:619-624.
23. Hong SJ, Chang CC. 1991. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor. Br J Pharmacol 102:817-822.
24. Katz B, Miledi R. 1977. Transmitter leakage from motor nerve endings. Proc R Soc B 169:59-72.
25. Kulak JM, McIntosh JM, Yoshikami D, Olivera B. 2001. Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. J Neurochem 77:1581-1589.
26. Kuryatov A, Olale F, Cooper J, Choi C, Lindstrom J. 2000. Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses. Neuropharmacology 39:2570-2590.
27. Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJK, Berg DK, Bertrand D, Chiappinell VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quick M, Taylor PW, Wonnacott S. 1999. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Res 51:397-401.
28. Magleby KL, Pallotta BS, Terrar DA. 1981. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog. J Physiol (Lond) 312:97-113.
29. Malinowski MN, Cannady SB, Schmit KV, Barr, PM, Schrock JW, Wilson DF. 1997. Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the rat. Neurosci Lett 230:81-84.
30. Matzner H, Parnas H, Parnas I. 1988. Presynaptic effects of d-tubocurarine on neurotransmitter release at the neuromuscular junction of the frog. J Physiol (Lond) 398:109-121.
31. Molenaar PC, Oen BS, Polak RL, van der Laaken AL. 1987. Surplus acetylcholine and acetylcholine release in the rat diaphragm. J Physiol (Lond) 385:147-167.
32. Nikolsky EE, Voronin VA, Oranska TL, Vyskocil F. 1991. The dependence of non-quantal acetylcholine release on the choline-uptake system in the mouse diaphragm. Pflügers Arch 418:74-78.
33. 3H]acetylcholine release from the rat motor nerve terminals. Eur J Neurosci 15:1728-1736.
34. Paton WD, Waud DR. 1967. The margin of safety of neuromuscular transmission. J Physiol (Lond) 191:59-90.
35. Pemberton KE, Prior C, Marshall IG. 1992. The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions. Br J Pharmacol 105:113-118.
36. 1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse. Eur J Pharmacol 327:103-108.
37. Salpeter MM, Marchaterre M, Harris R. 1988. Distribution of extra-junctional acetylcholine receptors on a vertebrate muscle: evaluated by using a scanning electron microscope autoradiography procedure. J Cell Biol 106:2087-2093.
38. Santafé MM, Salon I, García N, Lanuza MA, Uchitel OD, Tomàs J. 2003. Modulation of ACh release by presynaptic muscarinic auto-receptors in the neuromuscular junction of the newborn and adult rat. Eur J Neurosci 17:119-127.
39. Schuetze SM, Role LW. 1987. Developmental regulation of nicotinic acetylcholine receptors. Annu Rev Neurosci 10:403-457.
40. 2+ release from intracellular stores. Proc Natl Acad Sci USA 98:4148-4153.
41. Silinsky EM, Redman RS. 1996. Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J Physiol (Lond) 492:815-822.
42. Silva HMV, Ambiel CR, Alves-do-Prado W. 1999. The neuromuscular transmission fade (Wedensky inhibition) induced by L-arginine in neuromuscular preparations from rats. Gen Pharmacol 32:705-712.
43. Singh S, Prior C. 1998. Prejunctional effects of the nicotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction. J Physiol (Lond) 511:451-460.
44. 3H]-dopamine release from rat striatal synaptosomes. Br J Pharmacol 132:785-791.
45. Tsuneki H, Kimura I, Dezaki K, Kimura M, Sala C, Fumagalli G. 1995. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 196:13-16.
46. Tsuneki H, Klink R, Léna C, Korn H, Changeux J-P. 2000. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci 12:2474-2485.
47. Vailati S, Hanke W, Bejan A, Barabino B, Longhi R, Balestra B, Moretti M, Clementi F, Gotti C. 1999. Functional α6-containing nicotinic receptors are present in chick retina. Mol Pharmacol 56: 11-19.
48. Van der Kloot W, Molgó J. 1994. Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol Rev 74:899-991.
49. Vernino S, Rogers M, Radcliffe KA, Dani JA. 1994. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J Neurosci 14:5514-5524.
50. Vizi ES, Somogyi GT. 1989. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation. Br J Pharmacol 97:65-70.
51. Vizi ES, Somogyi GT, Nagashima H, Chaudhry IA, Kobayashi O, Goldiner PL, Foldes FF. 1987. Tubocurarine and pancuronium inhibit evoked of acetylcholine from the mouse hemidiaphragm preparation. Br J Anaesth 59:226-231.
52. Vizi ES, Sershen H, Balla A, Mike A, Windisch K, Juranyi Z, Lajtha A. 1995. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann N Y Acad Sci 757:84-99.
53. Vizi ES, Nitahara K, Sato K, Sperlagh B. 2000. Stimulation-dependent release, breakdown, and action of endogenous ATP in mouse hemidiaphragm preparation: the possible role of ATP in neuromuscular transmission. J Auton Nerv Syst 81:278-284.
54. Waud BE, Waud DR. 1971. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Anesthesiology 35:456-464.
55. Wessler I. 1989. Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol Sci 10:110-114.
56. 3H]-acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmied Arch Pharmacol 334:357-364.
57. Wilson DF, Nicholson GM. 1997. Presynaptic snake β-neurotoxins produce tetanic fade and endplate potential run-down during neuromuscular blockade in mouse diaphragm. Naunyn Schmied Arch Pharmacol 356:626-634.
58. Wilson DF, West AE, Lin Y. 1995. Inhibitory action of nicotinic antagonists on transmitter release at the neuromuscular junction of the rat. Neurosci Lett 186:29-32.
59. Wonnacott S. 1997. Presynaptic nicotinic receptors. Trends Neurosci 20:92-98.
60. Wood SJ, Slater CR. 2001. Safety factor at the neuromuscular junction. Prog Neurobiol 64:393-429.